1. Why Immunoassay Methodology Changes the Workflow
IVD immunoassays are not defined by a single “best” technology. Colloidal-gold lateral flow tests prioritize simplicity and rapid visual readout; fluorescence immunoassays add reader-based quantitative detection; automated CLIA platforms use chemiluminescent signals for sensitive quantitative testing, often with solid-phase separation and wash steps. The practical choice depends on the assay target, required analytical performance, testing volume and care setting.
2. A Practical Methodology Comparison
|
Method
|
Signal / label
|
Quantitation
|
Typical separation / wash
|
Operational profile
|
|
Colloidal gold LFIA
|
Visible colored nanoparticles
|
Usually qualitative or semi-quantitative; readers may add quantitation
|
Usually none
|
Very simple, rapid, low instrument burden
|
|
FIA
|
Fluorescent labels detected by an optical reader
|
Quantitative
|
Often none in lateral-flow formats
|
Rapid reader-based POCT; portable platforms available
|
|
Conventional automated CLIA
|
Chemiluminescent labels (e.g., acridinium or enzyme systems)
|
Quantitative
|
Commonly solid-phase separation and wash
|
High automation; typically larger instrument and fluidic workflow
|
|
Poclight C5000
|
Homogeneous CRET-based CLIA
|
Quantitative
|
No magnetic-bead wash or physical bound/free separation in the CRET workflow
|
Compact, semi-automated, 7 independent channels
|
3. C5000: A Different Way to Build CLIA
Poclight C5000 uses a homogeneous chemiluminescence immunoassay based on CRET (chemiluminescence resonance energy transfer). In the company’s assay design, acridinium ester provides the chemiluminescent signal while graphene oxide acts as a quencher. Immune-complex formation changes the donor–quencher relationship, allowing signal discrimination without a conventional magnetic-bead separation and washing sequence. This is the central workflow difference behind the platform’s compact architecture.
4. C5000 Product Advantages
|
Platform item
|
C5000 information
|
|
Methodology
|
CRET-based homogeneous chemiluminescence immunoassay
|
|
Reagent format
|
Single-use lyophilized beads; 2–30°C storage; validated shelf life up to 18 months
|
|
Speed
|
First result as fast as 3 min; assay durations commonly 3–15 min
|
|
Parallel testing
|
7 independent detection channels
|
|
Throughput
|
Up to 80 tests/hour
|
|
Footprint
|
325 × 231 × 213 mm; ≤8.5 kg
|
|
Sample types
|
Serum and plasma for most assays; whole blood only for assays validated for that matrix
|
|
Workflow
|
Add sample → load reagent → read result; no magnetic-bead washing step
|
|
Operational value
|
Compact placement, lower fluidic complexity and simplified reagent logistics for decentralized or mid-/low-throughput testing
|
